摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-(benzo[b]thiophen-3-yl)-3-(4-benzyl-5,6-dihydropyridin-1(2H)-yl)propan-1-ol | 1394204-60-4

中文名称
——
中文别名
——
英文名称
1-(benzo[b]thiophen-3-yl)-3-(4-benzyl-5,6-dihydropyridin-1(2H)-yl)propan-1-ol
英文别名
1-(1-benzothiophen-3-yl)-3-(4-benzyl-3,6-dihydro-2H-pyridin-1-yl)propan-1-ol
1-(benzo[b]thiophen-3-yl)-3-(4-benzyl-5,6-dihydropyridin-1(2H)-yl)propan-1-ol化学式
CAS
1394204-60-4
化学式
C23H25NOS
mdl
——
分子量
363.524
InChiKey
QXCOEFGWAUGVTR-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.6
  • 重原子数:
    26
  • 可旋转键数:
    6
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.3
  • 拓扑面积:
    51.7
  • 氢给体数:
    1
  • 氢受体数:
    3

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    1-(benzo[b]thiophen-3-yl)-3-(4-benzyl-5,6-dihydropyridin-1(2H)-yl)propan-1-ol盐酸potassium carbonateN,N-二异丙基乙胺 作用下, 以 乙醇乙腈 为溶剂, 反应 21.0h, 生成 1-(3-(benzo[b]thiophen-3-yl)-3-(piperazin-1-yl)propyl)-4-benzyl-1,2,3,6-tetrahydropyridine hydrochloride
    参考文献:
    名称:
    芳烷基二胺衍生物作为潜在的三重再摄取抑制剂的合成及药理研究
    摘要:
    设计,合成了一系列芳烷基二胺衍生物,并对其三重再摄取抑制能力进行了评估。化合物18c(5-HT,NE,DA,IC 50  = 389,69,238 nM),36a(5-HT,NE,DA,IC 50  = 378,477,247 nM)和36d(5-HT, NE,DA,IC 50  = 501、206、357 nM)在大鼠强迫游泳试验中以5、10和20 mg / kg PO表现出体内活性。36a被确定为本研究中最有前途的候选人。具体而言,36a对许多中枢神经系统相关靶标的单胺转运蛋白表现出高选择性。此外,36a 在临床前研究中显示出良好的药代动力学性质和可接受的安全性。
    DOI:
    10.1016/j.ejmech.2014.08.045
  • 作为产物:
    描述:
    4-benzyl-1,2,3,6-tetrahydropyridine hydrochloride盐酸 、 sodium tetrahydroborate 作用下, 以 甲醇乙醇 为溶剂, 反应 8.0h, 生成 1-(benzo[b]thiophen-3-yl)-3-(4-benzyl-5,6-dihydropyridin-1(2H)-yl)propan-1-ol
    参考文献:
    名称:
    Synthesis and antidepressant activity of arylalkanol-piperidine derivatives as triple reuptake inhibitors
    摘要:
    A series of arylalkanol-piperidine derivatives was synthesized, and their triple reuptake inhibition and in vivo activities have been evaluated. Among them, compounds 2a, 2j, 2k, 2m and 2n exhibited high potency for 5-HT, NA and DA transporters. Optimized compounds 2j and 2m showed significant reduction of immobility time compared to that of vehicle in the mouse tail suspension test (TST) test at doses ranging from 10 to 50 mg/kg po, and were not generally motor stimulants at 50 mg/kg dose. In addition, compounds 2j and 2m displayed desirable pharmacokinetic properties in SD rats. (C) 2012 Elsevier Masson SAS. All rights reserved.
    DOI:
    10.1016/j.ejmech.2012.04.030
点击查看最新优质反应信息

文献信息

  • Synthesis and antidepressant activity of arylalkanol-piperidine derivatives as triple reuptake inhibitors
    作者:Yong-Yong Zheng、Lin Guo、Xue-Chu Zhen、Jian-Qi Li
    DOI:10.1016/j.ejmech.2012.04.030
    日期:2012.8
    A series of arylalkanol-piperidine derivatives was synthesized, and their triple reuptake inhibition and in vivo activities have been evaluated. Among them, compounds 2a, 2j, 2k, 2m and 2n exhibited high potency for 5-HT, NA and DA transporters. Optimized compounds 2j and 2m showed significant reduction of immobility time compared to that of vehicle in the mouse tail suspension test (TST) test at doses ranging from 10 to 50 mg/kg po, and were not generally motor stimulants at 50 mg/kg dose. In addition, compounds 2j and 2m displayed desirable pharmacokinetic properties in SD rats. (C) 2012 Elsevier Masson SAS. All rights reserved.
  • Synthesis and pharmacological investigation of aralkyl diamine derivatives as potential triple reuptake inhibitors
    作者:Yong-Yong Zheng、Zhi-Jie Weng、Peng Xie、Mei-Yu Zhu、Long-Xuan Xing、Jian-Qi Li
    DOI:10.1016/j.ejmech.2014.08.045
    日期:2014.10
    A series of aralkyl diamine derivatives were designed, synthesized, and evaluated for their triple reuptake inhibitory abilities. Compounds 18c (5-HT, NE, DA, IC50 = 389, 69, 238 nM), 36a (5-HT, NE, DA, IC50 = 378, 477, 247 nM), and 36d (5-HT, NE, DA, IC50 = 501, 206, 357 nM) showed in vivo activities in the rat forced swim test at 5, 10, and 20 mg/kg PO. 36a was identified as the most promising candidate
    设计,合成了一系列芳烷基二胺衍生物,并对其三重再摄取抑制能力进行了评估。化合物18c(5-HT,NE,DA,IC 50  = 389,69,238 nM),36a(5-HT,NE,DA,IC 50  = 378,477,247 nM)和36d(5-HT, NE,DA,IC 50  = 501、206、357 nM)在大鼠强迫游泳试验中以5、10和20 mg / kg PO表现出体内活性。36a被确定为本研究中最有前途的候选人。具体而言,36a对许多中枢神经系统相关靶标的单胺转运蛋白表现出高选择性。此外,36a 在临床前研究中显示出良好的药代动力学性质和可接受的安全性。
查看更多

同类化合物